Key facts
- This page summarizes Section 32 Fund 3, LP's Form 4 filing for DA32 Life Science Tech Acquisition Corp..
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 09 Aug 2021, 21:54.
Section 32 Fund 3, LP - 05 Aug 2021 Form 4 Insider Report for DA32 Life Science Tech Acquisition Corp.
- Reporting relationship
- Director, Director by Deputization, 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 05 Aug 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Aug 2021, 21:54:10 UTC
- Prior SEC filing
- 03 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Henrikki Harsu, Attorney-in-Fact for Section 32 Fund 3, LP
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Section 32 Fund 3, LP filed Form 4 for DA32 Life Science Tech Acquisition Corp. on 09 Aug 2021.
Change
- Previous filing in this sequence was filed on 03 Aug 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DALS
transaction
Derivative
Class B Common Stock, par value $0.0001 per share
Disposed to Issuer
- Transaction value
- $0
- Shares
- -701,250
- Change %
- -13%
- Price
- $0.000000
- Shares after
- 4,695,000
- Date
- 05 Aug 2021
- Ownership
- Through DA32 Sponsor LLC
- Underlying class
- Class A Common Stock
- Underlying amount
- 701,250
- Exercise price
- Footnotes
- F1, F2, F3, F4
DALS
transaction
Derivative
Class B Common Stock, par value $0.0001 per share
Disposed to Issuer
- Transaction value
- $0
- Shares
- -30,000
- Change %
- -0.64%
- Price
- $0.000000
- Shares after
- 4,665,000
- Date
- 05 Aug 2021
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 30,000
- Exercise price
- Footnotes
- F1, F3, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The shares of Class B Common Stock are convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Shares" in the Issuer's Registration Statement on Form S-1 File No. 333-257679) (the "Registration Statement") and have no expiration date.
Footnote F2
On August 5, 2021, DA32 Sponsor LLC ("Sponsor") forfeited 701,250 shares of Class B Common Stock to the Issuer for no consideration, which was exempted pursuant to Rule 16b-3(e) under the Securities Exchange Act of 1934, as amended, in connection with the underwriters' election to forfeit their overallotment option on August 4, 2021. The forfeiture was not within the Reporting Persons' control as it occurred exclusively due to the underwriters' decision not to exercise the overallotment option and occurred shortly after the Issuer filed the final statutory prospectus for the initial public offering (the "IPO") disclosing all material information about the Issuer and the IPO.
Footnote F3
This Form 4 is filed jointly by Section 32 Fund 3, LP ("S32 Fund"), Section 32 GP 3, LLC ("S32 GP") and William J. Maris (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
Footnote F4
Sponsor is the record holder of the securities reported herein. As a managing member of Sponsor, S32 Fund may be deemed to beneficially own the securities owned directly by Sponsor. As the general partner of S32 Fund, S32 GP may be deemed to beneficially own the securities owned directly by Sponsor. As the sole Managing Member of S32 GP, William J. Maris may be deemed to beneficially own securities owned directly by Sponsor.
Footnote F5
On August 5, 2021, the Reporting Persons forfeited 30,000 shares of Class B Common Stock to the Issuer for no consideration, which was exempted pursuant to Rule 16b-3(e) under the Securities Exchange Act of 1934, as amended, in connection with the underwriters' election to forfeit their overallotment option on August 4, 2021. The forfeiture was not within the Reporting Persons' control as it occurred exclusively due to the underwriters' decision not to exercise the overallotment option and occurred shortly after the Issuer filed the final statutory prospectus for the IPO disclosing all material information about the Issuer and the IPO.
SEC remarks
See Exhibit 99.1 - Joint Filer Information, which is incorporated herein by reference and describes in further detail the relationships of the Reporting Persons to the Issuer. Henrikki Harsu, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24.1, 24.2 and 24.3 to a Form 3 with regard to DA32 Life Science Tech Acquisition Corp. filed with the Securities and Exchange Commission on July 27, 2021 by Section 32 Fund 3, LP, Section 32 GP 3, LLC and William J Maris. Steve Kafka, an employee of Section 32 Fund 3, LP, serves as a director of the Issuer.